Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
July 31, 2026 80.07%
April 30, 2026 81.11%
January 31, 2026 78.66%
October 31, 2025 77.54%
July 31, 2025 76.46%
April 30, 2025 42.97%
January 31, 2025 73.08%
October 31, 2024 70.40%
July 31, 2024 71.02%
April 30, 2024 71.19%
January 31, 2024 63.51%
October 31, 2023 65.57%
July 31, 2023 66.90%
April 30, 2023 59.67%
January 31, 2023 48.35%
October 31, 2022 58.79%
July 31, 2022 54.34%
April 30, 2022 59.39%
January 31, 2022 38.51%
October 31, 2021 44.06%
July 31, 2021 26.40%
April 30, 2021 30.36%
January 31, 2021 32.99%
October 31, 2020 33.93%
July 31, 2020 20.05%
Date Value
April 30, 2020 2.09%
January 31, 2020 17.97%
October 31, 2019 25.12%
July 31, 2019 21.48%
April 30, 2019 12.55%
January 31, 2019 -24.00%
October 31, 2018 11.28%
July 31, 2018 18.86%
April 30, 2018 17.01%
January 31, 2018 27.10%
October 31, 2017 36.65%
July 31, 2017 14.92%
April 30, 2017 94.01%
January 31, 2017 -13.51%
October 31, 2016 13.53%
July 31, 2016 31.84%
April 30, 2016 24.29%
January 31, 2016 -762.7%
October 31, 2015 -688.3%
July 31, 2015 2.49%
April 30, 2015 58.14%
January 31, 2015
October 31, 2014
July 31, 2014
April 30, 2014 47.29%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Healios KK -886.3%
GNI Group Ltd. 71.81%
AnGes, Inc. 51.92%
ACADIA Pharmaceuticals, Inc. 90.81%
Alkermes Plc 75.30%

Gross Profit Margin (Quarterly) Related Metrics